Zacks.com on MSN14h
CTLT Stock Falls as Potential Hindrance to NVO Buyout Deal Increases
Shares of Catalent CTLT lost 0.9% on Oct. 23 with the rise in uncertainty related to its acquisition by Novo Holding ...
Roche CEO says antitrust regulators should block Catalent sale to Novo Holdings (update)
Roche CEO opposes Novo Nordisk's acquisition of Catalent, citing concerns about competition in the ...
bovnews1d
The Catalent Inc Stock Thriller: Decoding the Mystery Behind CTLT’s Recent Movements
On Tuesday, Catalent Inc (CTLT) stock saw a decline, ending the day at $59.92 which represents a decrease of $-0.26 or -0.43% from the prior close of $60.18. The stock opened at $60.14 and touched a ...
Nasdaq1mon
Catalent (CTLT) Upgraded to Strong Buy: Here's What You Should Know
Investors might want to bet on Catalent (CTLT), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...
Yahoo Finance17d
Catalent, Inc. (CTLT)
SOMERSET, N.J., August 29, 2024--Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced financial results for ...
bovnews13d
Catalent Inc (CTLT) Stock: More Strategic Than Meets the Eye
On Thursday, Catalent Inc (CTLT) stock saw a decline, ending the day at $60.71 which represents a decrease of $-0.25 or -0.41% from the prior close of $60.96. The stock opened at $60.78 and touched a ...
Consumer, labor groups urge FTC to block Catalent sale to Novo Holdings - report
Financial groups and labor unions urge FTC to block Nordisk Foundation's acquisition of Catalent, citing concerns about ...